Company
Epigenic
Pioneering Epigenetic Medicine
Also known as Epigenic (Shanghai) Biotechnology Co., Ltd., Epigenic Therapeutics
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Shanghai, China
- Founded
- 2021
- Legal name
- Epigenic (Shanghai) Biotechnology Co., Ltd.
- epigenictx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next-generation gene modulation therapy utilizing regulation of epigenetic genome for a variety of diseases.
Funding snapshot
- Total raised
- $60MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $60M2025-09-08
Funding rounds
- Series B
- $60M2025-09-08, Company stated
Loading relationship preview